IL89313A0 - Method for producing a recombinant protein derived from the circumsporozoite gene of plasmodium falciparum - Google Patents
Method for producing a recombinant protein derived from the circumsporozoite gene of plasmodium falciparumInfo
- Publication number
- IL89313A0 IL89313A0 IL89313A IL8931389A IL89313A0 IL 89313 A0 IL89313 A0 IL 89313A0 IL 89313 A IL89313 A IL 89313A IL 8931389 A IL8931389 A IL 8931389A IL 89313 A0 IL89313 A0 IL 89313A0
- Authority
- IL
- Israel
- Prior art keywords
- producing
- recombinant protein
- plasmodium falciparum
- protein derived
- circumsporozoite gene
- Prior art date
Links
- 241000223960 Plasmodium falciparum Species 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15786488A | 1988-02-19 | 1988-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL89313A0 true IL89313A0 (en) | 1989-09-10 |
Family
ID=22565606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL89313A IL89313A0 (en) | 1988-02-19 | 1989-02-16 | Method for producing a recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0329257A3 (xx) |
| JP (1) | JPH025888A (xx) |
| KR (1) | KR890013181A (xx) |
| AU (1) | AU625713B2 (xx) |
| BR (1) | BR8900697A (xx) |
| IL (1) | IL89313A0 (xx) |
| ZA (1) | ZA891169B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9002512D0 (en) * | 1990-02-05 | 1990-04-04 | 3I Res Expl Ltd | Polypeptides and dna encoding same |
| CA2037151A1 (en) * | 1990-03-23 | 1991-09-24 | F. Hoffmann-La Roche Ag | Plasmodium sporozoite antigen |
| US6855316B1 (en) | 1994-02-14 | 2005-02-15 | University Of Hawaii | Baculovirus produced Plasmodium falciparum vaccine |
| US6420523B1 (en) * | 1992-04-13 | 2002-07-16 | University Of Hawaii | Baculovirus produced plasmodium falciparum vaccine |
| NZ513549A (en) * | 1999-02-18 | 2003-03-28 | Rmf Dictagene S | Malaria vaccine |
| US20030100106A1 (en) | 2000-02-08 | 2003-05-29 | Chang Sandra P. | Baculovirus produced Plasmodium falciparum vaccine |
| US7037681B2 (en) | 2000-02-08 | 2006-05-02 | University Of Hawaii | Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants |
| AT501429B1 (de) * | 2004-11-23 | 2007-05-15 | Nessler Medizintechnik Gmbh | Verfahren zur durchkontaktierung |
| JP4828312B2 (ja) * | 2006-06-05 | 2011-11-30 | 日本圧着端子製造株式会社 | 防水コネクタ |
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8404378D0 (en) * | 1984-02-20 | 1984-03-28 | Biogen Nv | Dna sequence recombinant dna molecules |
| IE60285B1 (en) * | 1985-12-18 | 1994-06-29 | Microgenesys Inc | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom |
| WO1988005817A1 (en) * | 1987-01-30 | 1988-08-11 | Smith Kline - Rit S.A. | Expression of the p. falciparum circumsporozoite protein by yeast |
| IL85905A0 (en) * | 1987-03-30 | 1988-09-30 | Univ New York | Immunogenic recombinant yeast expression product and method for purifying it |
-
1989
- 1989-02-14 AU AU29924/89A patent/AU625713B2/en not_active Ceased
- 1989-02-15 ZA ZA891169A patent/ZA891169B/xx unknown
- 1989-02-16 JP JP1037287A patent/JPH025888A/ja active Pending
- 1989-02-16 IL IL89313A patent/IL89313A0/xx unknown
- 1989-02-17 EP EP89200394A patent/EP0329257A3/en not_active Withdrawn
- 1989-02-17 KR KR1019890001837A patent/KR890013181A/ko not_active Application Discontinuation
- 1989-02-17 BR BR898900697A patent/BR8900697A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2992489A (en) | 1989-08-24 |
| AU625713B2 (en) | 1992-07-16 |
| EP0329257A2 (en) | 1989-08-23 |
| JPH025888A (ja) | 1990-01-10 |
| BR8900697A (pt) | 1989-10-17 |
| KR890013181A (ko) | 1989-09-21 |
| ZA891169B (en) | 1989-11-29 |
| EP0329257A3 (en) | 1990-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT52963A (en) | Process for production of recombinant coccidiose vaccines | |
| ZA891169B (en) | Method for producing a recombinant protein derived from the circumsporozoite gene of plasmodium falciparum | |
| AU5112990A (en) | Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum | |
| NZ215034A (en) | Production of plasmodium falciparum cs protein | |
| AU5293486A (en) | Malaria vaccine against plasmodium falciparum | |
| NZ223174A (en) | Peptides and multimers immunologically related to circumsporozoite protein; vaccines against plasmodium falciparum-induced malaria | |
| ZA894182B (en) | Method for producing nonhyperglycosylated hepatitis b virus proteins | |
| GB2176191B (en) | Antigens of plasmodium falciparum | |
| IL94063A0 (en) | Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods | |
| YU237588A (en) | Process for preparing plasmodium falciparum proteins | |
| HU9403070D0 (en) | Improved method for recombinant protein production | |
| EP0217877A4 (en) | VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM. | |
| AU2384688A (en) | Monoclonal antibodies to a plasmodium falciparum protein | |
| AU2609588A (en) | Rhoptry antigen of plasmodium falciparum | |
| GB8919064D0 (en) | Plasmodium merozoite rhoptries antigen | |
| AU7163091A (en) | Novel malarial sporozoite peptide antigens | |
| IE901300L (en) | Plasmodium circumsporozoite protein analogues | |
| AU7699887A (en) | Merozoite surface antigen of plasmodium falciparum | |
| AU3069989A (en) | Rhoptry membrane antigen of plasmodium falciparum | |
| IL100391A0 (en) | A method for enhancing the structural stability of recombinant dna expression vectors | |
| GB8929002D0 (en) | Method of producing a polypeptide | |
| IE894106L (en) | Expression of the plasmodium circumsporozite protein in¹insects | |
| NZ221114A (en) | Merozoite surface antigen of plasmodium falciparum | |
| IL92775A (en) | Immunogenic peptide comprising a repetitive amino acid sequence of the immunodominant epitope of plasmodium circumsporozoite protein | |
| GB2200641B (en) | Merozoite surface antigen of plasmodium falciparum |